Highest-materiality recent filing
Q1 revenue $6.34M, net loss $2.12M; Vertiv 1 MW chiller order imminent
Revenue $6.34M vs $7.28M YoY; net loss $2.12M ($0.07 EPS) vs loss $0.66M.
Tecogen FY2025 revenue $27.1M (+20% YoY); net loss widens to $8.25M from $4.76M
FY2025 revenue $27.07M (19.7% increase); net loss $8.25M ($0.30/share) vs $4.76M loss in 2024.
Tecogen details data center cooling applications; 50-75 chillers per 250MW facility
Post on LinkedIn and website cites NVIDIA CEO comment, touts Tecogen natural gas and hybrid chillers.
Tecogen Reports Q3 2025 Revenue of $7.18M, Net Loss of $2.13M
Revenue increased 27.6% to $7.18M from $5.63M in Q3 2024, driven by 114.5% growth in product sales.
Tecogen Q2 revenue surges 54% to $7.29M; net loss narrows; data center LOI received
Revenue $7.29M (+54% YoY) driven by product sales surge (2,537%) from hybrid chiller deliveries.
Tecogen closes $19.9M public offering of 3.985M shares at $5.00 per share
Closed underwritten public offering of 3,985,000 shares (including 485,000 overallotment) at $5.00/share.
Tecogen prices public offering of 3.5M shares at $5 per share; net proceeds ~$16.3M
Offering of 3,500,000 shares at $5.00 per share; gross proceeds ~$17.5M.
Tecogen Q1 revenue up 17.6% to $7.28M; net loss narrows to $0.66M
Revenue $7.28M (+17.6% YoY); net loss $0.66M vs $1.10M a year ago; EPS -$0.03.
Tecogen Q4 rev $6.08M, net loss narrows to $1.19M; signs Vertiv partnership
Q4 revenue $6.08M (+3% YoY); net loss $1.19M vs $1.85M in Q4 2023; EPS -$0.05.
Tecogen partners with Vertiv for data center cooling chillers; exclusive rights outside US
Vertiv gets exclusive rights to market Tecogen DTx Chillers for data center cooling outside US; non-exclusive within US.
Tecogen Q3 revenue down 20.8% to $5.63M; net loss widens to $0.93M
Revenue $5.63M vs $7.11M YoY (-20.8%); net loss $0.93M vs $0.48M; EPS loss $0.04.
Tecogen Q2 revenue down 30% to $4.7M; net loss widens to $1.54M on factory relocation
Revenue $4.7M (down 29.9% YoY); net loss $1.54M vs $0.78M loss; EPS -$0.06 per share.
Tecogen shareholders reject reverse stock split at annual meeting; all director nominees elected
Reverse stock split (1-for-4 to 1-for-6) failed with 42.18% of outstanding shares voting in favor, below required majority.
Tecogen Q4 2023 revenue $5.9M (+30% YoY); net loss $1.8M on $1M bad debt and inventory charges
Revenue $5.9M in Q4 (+30.2% YoY); Products $1.8M (+76.6%), Services $3.6M (+19.1%), Energy $542K (+4.7%).
Tecogen Q3 2023 revenue up 7.5% YoY to $7.1M; net loss widens to $0.5M
Q3 revenue $7.1M (up 7.5% YoY); net loss $0.5M ($0.02 EPS) vs loss $0.3M a year ago.
Tecogen secures up to $1.5M insider loans; board to seek reverse stock split approval
Directors Hatsopoulos and Lewis commit up to $1M and $500K-$1M respectively in loans for working capital.
Tecogen Q2 2023 revenue $6.7M (+5.2% YoY); net loss narrows to $0.8M; backlog rises to $11.3M
Q2 revenue $6.7M (up 5.2% from $6.4M in Q2 2022); net loss $0.8M (improved from $0.9M); EPS loss $0.03.
Tecogen Q1 2023 revenue down 27.7% to $5.4M, net loss of $1.5M vs prior year profit
Revenue $5.4M, down 27.7% YoY; net loss $1.5M vs net income $0.1M in Q1 2022.
Tecogen discloses ransomware attack on April 28; network restored by May 1
Attack was a spear phishing attempt via the company's VPN; traces found on two workstations.
Tecogen acquires 202 maintenance contracts, assets from Aegis; reports Q4 earnings
Definitive agreement to assume 202 cogeneration maintenance agreements; closing targeted April 1, 2023.
Tecogen Q3 revenue up 31.9% to $6.6M; net loss $0.3M vs $1.5M profit
Revenue $6.6M in Q3 2022, up 31.9% YoY from $5.0M; YTD revenue $20.5M (+18.9%).
Tecogen Q2 2022 revenue up 4.4% to $6.4M but net loss of $856K vs profit in prior year
Net loss of $856K ($0.03 EPS loss) vs net income of $399K ($0.02 EPS) in Q2 2021 due to absence of CARES Act credits.
On February 14, 2025, Mr. Joseph E. Gehret, formerly Vice President of Operations, left the Company to pursue another opportunity.
the Board of Directors of Tecogen Inc. is deeply saddened to announce that, on December 12, 2023, it was informed of the death, on December 9, 2023, of Mr. Fred Holubow, a director of the company and a member of the board’s Audit Committee since June 2020.
On September 22, 2023, the Board of Directors of Tecogen Inc. (“registrant”) appointed Ms. Susan B. Hirsch to serve as an independent non-employee director of registrant to fill a vacancy in registrant’s board of directors.
On January 30, 2023, Tecogen Inc. (the “Company”) issued a press release announcing that the Company’s Board of Directors appointed Dr. Abinand Rangesh to serve as the CEO of the Company effective January 30, 2023.
Also on January 30, 2023 Benjamin M. Locke resigned as CEO and as a director of the Company and its affiliates effective January 30, 2023
On December 7, 2022, Tecogen Inc. (the “Company”) announced that Dr. John M. Albertine has been appointed as a director of the Company and a member of the Company’s Audit Committee.
On September 19, 2022, Ralph Jenkins, a director of Tecogen Inc. (the “Company”) notified the Company of his resignation as a director of the Company effective immediately in order to permit him to focus on other business and personal commitments.
Max materiality 0.80 · Median 0.55 · Most common event other_material